Development of influenza A antivirals

Access full-text files

Date

2016-11-22

Authors

Robert M. Krug
Karen Y. Twu

Journal Title

Journal ISSN

Volume Title

Publisher

United States Patent and Trademark Office

Abstract

The present invention includes compositions, methods and systems to isolate and characterize novel antiviral agents by contacting the antiviral agent with the F2F3 zinc fingers of a CPSF30 protein and an Influenza A NS1A protein; and determining whether the binding between the CPSF30 protein and the Influenza A NS1A protein is reduced.

Description

Keywords

LCSH Subject Headings

Citation